secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0000950170-25-114530
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Benitec restates Q2 and Q3 FY2025 financials for stock-comp understatement; prior filings unreliable
--------------------------------------------------------------------------------

- Audit Committee concluded Dec 31, 2024 and Mar 31, 2025 unaudited financials should no longer be relied upon.
- Error from November 2023 system migration incorrectly configured equity awards data, understating share-based compensation.
- Non-cash adjustments understated additional paid-in capital, accumulated deficit, net loss, and loss per share.
- Restated financials to be included in FY2025 Form 10-K, expected to be filed on or before the deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000095017025114530/0000950170-25-114530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000095017025114530/bntc-20250910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-114530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer